My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
WORK PLANS
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
I
>
INDUSTRIAL
>
1010
>
2900 - Site Mitigation Program
>
PR0546521
>
WORK PLANS
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/13/2026 2:55:24 PM
Creation date
3/13/2026 2:46:24 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
WORK PLANS
RECORD_ID
PR0546521
PE
2950 - ENVIRON ASSESS
FACILITY_ID
FA0026379
FACILITY_NAME
PARDEE INDUSTRIAL DRIVE LLC
STREET_NUMBER
1010
STREET_NAME
INDUSTRIAL
STREET_TYPE
DR
City
STOCKTON
Zip
95206
CURRENT_STATUS
Active, billable
QC Status
Approved
Scanner
SJGOV\gmartinez
Supplemental fields
Site Address
1010 INDUSTRIAL DR STOCKTON 95206
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
26
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
AdvancedGeo, Inc. AdvancedGeo <br /> An E�oye"wnedCompany <br /> Coronavirus (Covid-19) Prevention and Control Plan ., <br /> Page 3 of 6 Q <br /> ➢ Appropriate PPE, hygiene and cleaning supplies <br /> Workplace Assessment per the Centers for Disease Control and Prevention (CDC) <br /> RISK LEVEL TRAVEL-ASSOCIATED EXPOSURES IDENTIFIED THROUGH CONTACT <br /> EXPOSURES INVESTIGATION <br /> High N/A Living in the same household as, being an intimate <br /> partner of, or providing care in a nonhealthcare setting <br /> (such as a home) for a person with symptomatic <br /> laboratory-confirmed COVID-19 infection without <br /> using recommended precautions for home care and <br /> home isolation <br /> Medium (Assumes no Travel from a country Close contact with a person with symptomatic <br /> exposures in the high-risk with widespread laboratory-confirmed COVID-19 <br /> category) sustained transmission On an aircraft, being seated within 6 feet(two meters) <br /> Travel from a country of a traveler with symptomatic laboratory-confirmed <br /> with sustained COVID-19 infection;this distance correlates <br /> community transmission approximately with 2 seats in each direction <br /> Travel on a cruise ship Living in the same household as, an intimate partner <br /> or river boat of, or caring for a person in a nonhealthcare setting <br /> (such as a home) to a person with symptomatic <br /> laboratory-confirmed COVID-19 infection while <br /> consistently using recommended precautions for <br /> home care and home isolation <br /> Low N/A Being in the same indoor environment(e.g., a <br /> (Assumes no exposures in classroom, a hospital waiting room) as a person with <br /> the high-risk category) symptomatic laboratory-confirmed COVID-19 for a <br /> prolonged period of time but not meeting the <br /> definition of close contact <br /> No identifiable risk N/A Interactions with a person with symptomatic <br /> laboratory-confirmed COVID-19 infection that do not <br /> meet any of the high-, medium-or low-risk conditions <br /> above, such as walking by the person or being briefly <br /> in the same room. <br /> PERSONNEL IN CRITICAL INFRASTRUCTURE POSITIONS <br /> Personnel who are permitted to work following an exposure should self-monitor under the <br /> supervision of our occupational health program, including taking their temperature before each <br /> work shift to ensure they remain afebrile. On days these individuals are scheduled to work, our <br /> occupational health program could consider measuring temperature and assessing symptoms prior <br /> to each employee starting work. <br /> PROCEDURES FOR MANAGEMENT OF EXPOSED PERSONS BY RISK <br /> LEVEL/PRESENCE OF SYMPTOMS <br /> The public health actions recommended in the table below apply to people who have been <br /> determined to have at least some risk for COVID-19. People who are being managed as <br /> asymptomatic in a particular risk level, or who develop signs or symptoms compatible with <br /> COVID-19, should be moved immediately into the symptomatic category in the same risk <br /> level and be managed accordingly. The risk level does not change if symptoms develop. <br />
The URL can be used to link to this page
Your browser does not support the video tag.